Q1
SCI Hakemli
Real-world 6 and 12-month Drug Retention, Remission and Response Rates of Secukinumab in 2017 patients with Psoriatic Arthritis in 13 European Countries
Arthritis Care & Research · 2022
PROFESÖR SEMA YILMAZ
Detay